Kelsey Scherler
Overview
Explore the profile of Kelsey Scherler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
1291
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumari S, Lausted C, Scherler K, Ng A, Lu Y, Lee I, et al.
Biomolecules
. 2025 Jan;
14(12.
PMID: 39766306
Extracellular vesicles (EVs) are lipid bilayer nanoparticles released from all known cells and are involved in cell-to-cell communication via their molecular content. EVs have been found in all tissues and...
2.
Nguyen K, Rima X, Nguyen L, Wang X, Kwak K, Yoon M, et al.
Adv Healthc Mater
. 2024 May;
14(3):e2400622.
PMID: 38820600
Virion-mediated outbreaks are imminent and despite rapid responses, continue to cause adverse symptoms and death. Therefore, tunable, sensitive, high-throughput assays are needed to help diagnose future virion-mediated outbreaks. Herein, it...
3.
Zhang J, Rima X, Wang X, Nguyen L, Huntoon K, Ma Y, et al.
J Extracell Vesicles
. 2023 Nov;
12(11):e12369.
PMID: 37908159
The molecular heterogeneity of extracellular vesicles (EVs) and the co-isolation of physically similar particles, such as lipoproteins (LPs), confounds and limits the sensitivity of EV bulk biomarker characterization. Herein, we...
4.
Ng A, Hu H, Wang K, Scherler K, Warren S, Zollinger D, et al.
Cell Rep
. 2023 Oct;
42(10):113212.
PMID: 37792533
Local immune activation at mucosal surfaces, mediated by mucosal lymphoid tissues, is vital for effective immune responses against pathogens. While pathogens like severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can...
5.
Park J, Fong Legaspi S, Schwartzman L, Gygli S, Sheng Z, Freeman A, et al.
Sci Transl Med
. 2022 Jul;
14(653):eabo2167.
PMID: 35857640
Influenza A viruses (IAVs) present major public health threats from annual seasonal epidemics and pandemics and from viruses adapted to a variety of animals including poultry, pigs, and horses. Vaccines...
6.
Su Y, Yuan D, Chen D, Ng R, Wang K, Choi J, et al.
Cell
. 2022 Feb;
185(5):881-895.e20.
PMID: 35216672
Post-acute sequelae of COVID-19 (PASC) represent an emerging global crisis. However, quantifiable risk factors for PASC and their biological associations are poorly resolved. We executed a deep multi-omic, longitudinal investigation...
7.
DAgnillo F, Walters K, Xiao Y, Sheng Z, Scherler K, Park J, et al.
Sci Transl Med
. 2021 Oct;
13(620):eabj7790.
PMID: 34648357
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is characterized by respiratory distress, multiorgan dysfunction, and, in some cases, death. The pathological mechanisms underlying...
8.
Giurgea L, Cervantes-Medina A, Walters K, Scherler K, Han A, Czajkowski L, et al.
J Infect Dis
. 2021 Aug;
225(4):715-722.
PMID: 34423369
Background: Preclinical animal studies and retrospective human studies suggest that adult females have worse outcomes from influenza than males. Prospective studies in humans are missing. Methods: Data from 164 healthy...
9.
Giurgea L, Park J, Walters K, Scherler K, Cervantes-Medina A, Freeman A, et al.
NPJ Vaccines
. 2021 Apr;
6(1):48.
PMID: 33824333
Despite the importance of immunity against neuraminidase (NA), NA content and immunogenicity are neglected in current influenza vaccines. To address this, a recombinant N1/N2 NA vaccine (NAV) was developed. Stability...
10.
Su Y, Chen D, Yuan D, Lausted C, Choi J, Dai C, et al.
Cell
. 2020 Nov;
183(6):1479-1495.e20.
PMID: 33171100
We present an integrated analysis of the clinical measurements, immune cells, and plasma multi-omics of 139 COVID-19 patients representing all levels of disease severity, from serial blood draws collected during...